FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025444015> ?p ?o ?g. }

• W2025444015 endingPage "340" @default.
• W2025444015 startingPage "339" @default.
• W2025444015 abstract "Research Articles| April 23 1999 A Comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus Placebo in Suppressing the Cutaneous Response to Histamine Subject Area: Immunology and Allergy J. Andrew Grant; J. Andrew Grant University of Texas Medical Branch, Galveston, Tex.,USA; Search for other works by this author on: This Site PubMed Google Scholar Linda Danielson; Linda Danielson UCB Pharma, Braine–l’Alleud, Belgium Search for other works by this author on: This Site PubMed Google Scholar Jean-Pierre Rihoux; Jean-Pierre Rihoux UCB Pharma, Braine–l’Alleud, Belgium Search for other works by this author on: This Site PubMed Google Scholar Christine DeVos Christine DeVos UCB Pharma, Braine–l’Alleud, Belgium Search for other works by this author on: This Site PubMed Google Scholar Int Arch Allergy Immunol (1999) 118 (2-4): 339–340. https://doi.org/10.1159/000024126 Article history Published Online: April 23 1999 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation J. Andrew Grant, Linda Danielson, Jean-Pierre Rihoux, Christine DeVos; A Comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus Placebo in Suppressing the Cutaneous Response to Histamine. Int Arch Allergy Immunol 1 April 1999; 118 (2-4): 339–340. https://doi.org/10.1159/000024126 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsInternational Archives of Allergy and Immunology Search Advanced Search Keywords: Cetirizine, Ebastine, Epinastine, Fexofenadine, Histamine, Histamine H1 antagonists, Loratadine, Terfenadine, Skin tests 1999Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed... 1999Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content." @default.
• W2025444015 created "2016-06-24" @default.
• W2025444015 creator A5031776480 @default.
• W2025444015 creator A5054937386 @default.
• W2025444015 creator A5083213306 @default.
• W2025444015 creator A5090629949 @default.
• W2025444015 date "1999-01-01" @default.
• W2025444015 modified "2023-10-17" @default.
• W2025444015 title "A Comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus Placebo in Suppressing the Cutaneous Response to Histamine" @default.
• W2025444015 cites W1984821080 @default.
• W2025444015 cites W1991790975 @default.
• W2025444015 cites W2022208863 @default.
• W2025444015 doi "https://doi.org/10.1159/000024126" @default.
• W2025444015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10224437" @default.
• W2025444015 hasPublicationYear "1999" @default.
• W2025444015 type Work @default.
• W2025444015 sameAs 2025444015 @default.
• W2025444015 citedByCount "14" @default.
• W2025444015 countsByYear W20254440152014 @default.
• W2025444015 crossrefType "journal-article" @default.
• W2025444015 hasAuthorship W2025444015A5031776480 @default.
• W2025444015 hasAuthorship W2025444015A5054937386 @default.
• W2025444015 hasAuthorship W2025444015A5083213306 @default.
• W2025444015 hasAuthorship W2025444015A5090629949 @default.
• W2025444015 hasConcept C1122143 @default.
• W2025444015 hasConcept C154945302 @default.
• W2025444015 hasConcept C199360897 @default.
• W2025444015 hasConcept C203357204 @default.
• W2025444015 hasConcept C2776711289 @default.
• W2025444015 hasConcept C2778447006 @default.
• W2025444015 hasConcept C2779303165 @default.
• W2025444015 hasConcept C2780734495 @default.
• W2025444015 hasConcept C41008148 @default.
• W2025444015 hasConcept C71924100 @default.
• W2025444015 hasConcept C98274493 @default.
• W2025444015 hasConceptScore W2025444015C1122143 @default.
• W2025444015 hasConceptScore W2025444015C154945302 @default.
• W2025444015 hasConceptScore W2025444015C199360897 @default.
• W2025444015 hasConceptScore W2025444015C203357204 @default.
• W2025444015 hasConceptScore W2025444015C2776711289 @default.
• W2025444015 hasConceptScore W2025444015C2778447006 @default.
• W2025444015 hasConceptScore W2025444015C2779303165 @default.
• W2025444015 hasConceptScore W2025444015C2780734495 @default.
• W2025444015 hasConceptScore W2025444015C41008148 @default.
• W2025444015 hasConceptScore W2025444015C71924100 @default.
• W2025444015 hasConceptScore W2025444015C98274493 @default.
• W2025444015 hasIssue "2-4" @default.
• W2025444015 hasLocation W20254440151 @default.
• W2025444015 hasLocation W20254440152 @default.
• W2025444015 hasOpenAccess W2025444015 @default.
• W2025444015 hasPrimaryLocation W20254440151 @default.
• W2025444015 hasRelatedWork W1483901519 @default.
• W2025444015 hasRelatedWork W1967541102 @default.
• W2025444015 hasRelatedWork W2003144915 @default.
• W2025444015 hasRelatedWork W2017009033 @default.
• W2025444015 hasRelatedWork W2117762428 @default.
• W2025444015 hasRelatedWork W2150391039 @default.
• W2025444015 hasRelatedWork W2171569907 @default.
• W2025444015 hasRelatedWork W2395000263 @default.
• W2025444015 hasRelatedWork W2438975569 @default.
• W2025444015 hasRelatedWork W4247909807 @default.
• W2025444015 hasVolume "118" @default.
• W2025444015 isParatext "false" @default.
• W2025444015 isRetracted "false" @default.
• W2025444015 magId "2025444015" @default.
• W2025444015 workType "article" @default.